Schoenberg Mark
UroGen Pharma Ltd. · Chief Medical Officer
Schoenberg Mark is listed in filings as Chief Medical Officer at UroGen Pharma Ltd.. This profile follows SEC Form 4 activity through Jun 24, 2026, including sale activity. Recent filings connect the profile to UroGen Pharma Ltd. (URGN). The current snapshot covers public activity from Jun 11, 2024 to Jun 24, 2026. Reported amounts are shown as $350.1K to $11.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $67k5.2k shares | SellJun 10, 2024 | $13.08 | $43.78 | |
| $11k859 shares | SellSep 9, 2024 | $13.08 | $43.78 | |
| $8.5k759 shares | SellJan 31, 2025 | $11.14 | $43.78 | |
| $21k1.9k shares | SellJan 31, 2025 | $11.14 | $43.78 | |
| $38k5.2k shares | SellJun 9, 2025 | $7.37 | $43.78 | |
| $99k5.1k shares | SellJul 28, 2025 | $19.14 | $43.78 | |
| $177k10k shares | SellAug 11, 2025 | $17.69 | $43.78 | |
| $17k871 shares | SellSep 8, 2025 | $19.11 | $43.78 | |
| $250k10k shares | SellNov 19, 2025 | $25.00 | $43.78 | |
| $73k3.7k shares | SellFeb 3, 2026 | $19.69 | $43.78 | |
| $36k1.8k shares | SellFeb 3, 2026 | $19.69 | $43.78 | |
| $36k1.8k shares | SellFeb 3, 2026 | $19.69 | $43.78 | |
| $300k10k shares | SellMay 8, 2026 | $30.00 | $43.78 |